Valeo Pharma Inc
F:VP2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Valeo Pharma Inc
F:VP2
|
CA |
|
M
|
McDonald's Corp
BMV:MCD
|
US |
|
B
|
Bausch Health Companies Inc
DUS:BVF
|
CA |
|
R
|
Reklaim Ltd
OTC:MYIDF
|
CA |
|
Arca Continental SAB de CV
BMV:AC
|
MX |
|
Energy of Minas Gerais Co
BMV:CIGN
|
BR |
|
T
|
Target Corp
F:DYH
|
US |
|
G50 Corp Ltd
OTC:GFTYF
|
AU |
|
T
|
Target Corp
XMUN:DYH
|
US |
|
Brunel International NV
AEX:BRNL
|
NL |
|
5
|
51job Inc
F:IWQ
|
CN |
|
P
|
Polytec Holding AG
VSE:PYT
|
AT |
|
O
|
Orkla ASA
XMUN:OKL
|
NO |
|
Polytec Holding AG
F:P4N
|
AT |
|
N
|
Neurocrine Biosciences Inc
F:NB3
|
US |
|
M
|
Metro Inc
OTC:MTRAF
|
CA |
Bankruptcy Probability
Valeo Pharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Valeo Pharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
Valeo Pharma Inc
TSX:VPH
|
4.4m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
601.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
315.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
235.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
195.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Valeo Pharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Valeo Pharma Inc has total debt of 27.8m CAD. This includes both short-term (3.4m CAD) and long-term (24.4m CAD) debt.
You can find a full breakdown on its Balance Sheet.
